Race and clinical outcome in endometrial carcinoma

Obstetrics and Gynecology

Volumn 94, Issue 5, 1999, Pages 713-720

  CONNELL, PHILIP P ^a   ROTMENSCH, JACOB ^a   WAGGONER, STEVE E ^a   MUNDT, ARNO J ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; CAUCASIAN; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; NEGRO; PRIORITY JOURNAL; PROGNOSIS; RACE; RACE DIFFERENCE; SOCIAL STATUS; SURVIVAL; TREATMENT OUTCOME;

AFRICAN AMERICANS; AGED; ENDOMETRIAL NEOPLASMS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SOCIOECONOMIC FACTORS;

EID: 0033231971     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/00006250-199911000-00014     Document Type: Article

References (34)

1. Miller BA, Ries LAG, Hankey BF, Kosary CL, Harras A, Devesa SS, et al. SEER cancer statistics review: 1973-1990. Bethesda, Maryland: National Cancer Institute MH Publication 1993;93:2789-91.
2. Aziz H, Rotman M, Hussain F, Smith G, Chan E, Choi K, et al. Poor survival of black patients in carcinoma of the endometrium. Int J Radiat Oncol Biol Phys 1993;27:293-301.
3. Aziz H, Hussain F, Edelman S, Cirrone J, Aral I, Fruchter R, et al. Age and race as prognostic factors in endometrial carcinoma. Am J Clin Oncol 1996;19:595-600.
4. Liu JB, Conaway M, Rodriguez GC, Soper JT, Clarke-Pearson DL, Berchuck A. Relationship between race and interval to treatment in endometrial cancer. Obstet Gynecol 1995;86:486-90.
5. Matthews RP, Hutchinson-Colas J, Maiman M, Fruchter RG, Gates EJ, Gibbon D, et al. Papillary serous and clear cell type lead to poor prognosis of endometrial carcinoma in black women. Gynecol Oncol 1997;65:206-12.
6. Hicks ML, Kim WS, Abrams J, Johnson CC, Blount AC, Parham GP. Racial differences in surgically staged patients with endometrial cancer. J Natl Med Assoc 1997;89:134-40.
7. Axtell LM, Myers MH. Contrasts in survival of black and white cancer patients, 1960-1973. J Natl Cancer Inst 1978;60:1209-15.
8. Young JL, Ries LG, Pollack ES. Cancer patient survival among ethnic groups in the United States. J Natl Cancer Inst 1984;73:341-52.
9. Steinhorn SC, Myers MH, Hankey BF, Pelham VF. Factors associated with survival differences between black women and white women with cancer of the uterine corpus. Am J Epidemiol 1986;124:85-93.
10. Bain RP, Greenberg S, Chung KC. Racial differences in survival of women with endometrial cancer. Am J Obstet Gynecol 1987;157:914-23.
11. Ragland KE, Selvin S, Merrill DW. Black-white differences in stage-specific cancer survival: Analysis of seven selected sites. Am J Epidemiol 1991;133:672-82.
12. Kosary CL. FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: An analysis of 1973-1987 SEER cases of cancers of the endometrium, cervix, ovary, vulva and vagina. Semin Surg Oncol 1994;10:31-46.
13. Christopherson WM, Connelly PJ, Alberhasky RC. Carcinoma of the endometrium. V. An analysis of prognosticators in patients with favorable subtypes and stage I disease. Cancer 1983;51:1705-9.
14. Young JL Jr, Devesa SS, Cutler SJ. Incidence of cancer in United States blacks. Cancer Res 1975;35:3523-36.
15. Barrett RJ, Harlan LC, Wesley MN, Hill HA, Chen VW, Clayton LA, et al. Endometrial cancer: Stage at diagnosis and associated factors in black and white patients. Am J Obstet Gynecol 1995;173:414-23.
16. Hill HA, Coates RJ, Austin H, Correa P, Robboy SJ, Chen V, et al. Racial differences in tumor grade among women with endometrial cancer. Gynecol Oncol 1995;56:154-63.
17. Hill HA, Eley JW, Harlan LC, Greenberg RS, Barrett RJ II, Chen VC. Racial differences in endometrial cancer survival: The Black/White Cancer Survival Study. Obstet Gynecol 1996;88:919-26.
18. Kohler MF, Carney P, Dodge R, Soper JT, Clark-Pearson DL, Marks JR, et al. p53 overexpression in advanced-stage endometrial cancer. Am J Obstet Gynecol 1996;175:1246-52.
19. International Federation of Gynecology and Obstetrics. Annual report of the results of treatment in gynecological cancer. Int J Gynaecol Obstet 1988;20:75-7.
20. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
21. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966;50:163-70.
22. Cox DR, Oakes D. Analysis of survival data. London: Chapman & Hall, 1984.
23. Howard J, Hankey BF, Greenberg RS, Austin DF, Correa P, Chen VW, et al. A collaborative study of differences in the survival rates of black patients and white patients with cancer. Cancer 1992;69:2349-60.
24. Schottenfeld D. Determinants of black/white survival differences among women with endometrial cancer [editorial]. Gynecol Oncol 1995;56:151-3.
25. Freeman H. Race, poverty and cancer. J Natl Cancer Inst 1991;83:526-7.
26. Morrow CP, Bundy BN, Kurman RJ, Creasman WT, Heller P, Homesley HD, et al. Relationship between surgical-pathological risk and outcome in clinical stage I and II carcinoma of the endometrium: A Gynecologic Oncology Group study. Gynecol Oncol 1991;40:55-65.
27. Plaxe SC, Saltzstein SL. Impact of ethnicity on the incidence of high-risk endometrial carcinoma. Gynecol Oncol 1997;65:8-12.
28. Shapiro S, Kelly JP, Rosenberg L, Kaufan DW, Helmrich SP, Rosenshein NB, et al. Risk of localized and widespread endometrial cancer in relation to recent and discontinued use of conjugated estrogens. N Engl J Med 1985;313:969-72.
29. McWhorter WP, Schatzkin AG, Horm JW, Brown CC. Contribution of socioeconomic status to black/white differences in cancer incidence. Cancer 1989;63:982-7.
30. Sherman ME, Sturgeon S, Brinton L, Kurman RJ. Endometrial cancer chemoprevention: Implications of diverse pathways of carcinogenesis. J Cell Biochem Suppl 1995;23:160-4.
31. Greenwald P, Sondik EJ. Cancer control objectives for the nation: 1985-2000. NCI Monogr 1986;2:1-105.
32. Welsh CW. Enhancement of mammary tumorigenesis by dietary fat: A review of potential mechanisms. Am J Clin Nutr 1987;45:192-202.
33. Cauley JA, Gutai JP, Kuller LH, Scott J, Nevitt MC. Black-white differences in serum sex hormones and bone mineral density. Am J Epidemiol 1994;139:1035-46.
34. Wright NM, Papadea N, Willi S, Vendhuis JD, Pandey JP, Key LL, et al. Demonstration of a lack of racial differences in secretion of growth hormone despite a racial difference in bone mineral density in pre-menopausal women—a Clinical Research Center study. J Clin Endocrinol Metab 1996;81:1023-6.